Phase I/II Trial of Temozolomide and ABT-888 in Subjects with Newly Diagnosed

Grant

Date/time Interval

  • April 28, 2010 - April 27, 2012
  • Total Award Amount

  • 18000.00
  • Direct Costs

  • 14286.00
  • Sponsor Award Id

  • M10
  • Contributor

  • Nabors M.D., Louis   Principal Investigator